Fed. Circ. Backs Pfizer's Patent For Cancer Drug Sutent
By Bonnie Eslinger ( January 13, 2016, 5:33 PM EST) -- Pfizer Inc. secured a win Wednesday in its bid to block Mylan Inc. from introducing a generic version of the blockbuster cancer drug Sutent when a Federal Circuit panel affirmed that Pfizer's patent for the medication could stand....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.